No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial

Authored by: Grijsen Marlous L., Steingrover Radjin, Wit Ferdinand W. N. M., Jurriaans Suzanne, Verbon Annelies, Brinkman Kees, van der Ende Marchina E., Soetekouw Robin, de Wolf Frank, Lange Joep M. A., Schuitemaker Hanneke, Prins Jan M.
In: PLOS MEDICINE 9(3), 2012, p.e1001196-